About Shasun Pharma
Shasun Pharma is a Healthcare company based in Chennai (India) founded in 1976 by Abhaya Kumar Srisrimal, and was acquired by Strides Arcolab in September 2014. Company manufacturing and offering CDMO services for APIs, intermediates and solid dosage forms. Shasun Pharma has raised $10 million across 1 funding round from investors including Orbimed and Strides Arcolab. The company has 661 employees. Shasun Pharma has completed 1 acquisition, including Vanquishheadacherelief. Its Indian entity Shasun Pharmaceuticals Limited reported revenue of ₹1,329 Cr. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides. Its competitors include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals; 1 of its 3 listed competitors has raised funding.
Company details
Shasun Pharmaceuticals makes drug ingredients and finished medicines, as well as provides contract research and manufacturing services. It supplies to North America, Europe, Asia and Latin America. The company offers formulation and generic manufacturing services at its Indian sites together with contract research and manufacturing services for APIs (Active Pharmaceutical Ingredients) in India and the UK. Its service portfolio includes analytical method development and validation, scale-up technology transfer, clinical supplies manufacturing and full-scale commercial manufacturing of oral solid dosage forms. The company claims to be one of the largest global producers of generic Ibuprofen and also to have expertise in enteric coating excipients. Shasuns manufacturing facilities are certified by US FDA, MHRA, ANVISA (Brazil) and COFEPRIS (Mexico). Shasun has acquired (Rhodia Pharma Solutions business, France) and formed JV alliances (Nanoparticle Biochem, US, and Alivira Animal Health ) with foreign and domestic partners. The company went public in 1996 and merged with Strides Arcolab in Nov 2015.
- Headquarters Chennai, India
- Employees 661
- Founders Abhaya Kumar Srisrimal
- Stage Acquired
- SectorsHealthcare
- Website shasun.com
- Social LinkedIn
- Acquired by Strides Arcolab (Sep 2014)
- Legal Name Shasun Pharmaceuticals Limited
- Date of Incorporation 19 Apr, 1976
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹1,329 Cr
FY 2015 · +8% YoY
- Total Equity Funding$10M (USD)
in 1 rounds
- Latest Funding Round$10M (USD), Series A
Feb 2012
- InvestorsOrbimed
& 1 more
- Employee Count661
- Investments & Acquisitions
- Acquired byStrides Arcolab
(Sep 2014)
Associated legal entities of Shasun Pharma
Shasun Pharma operates through Shasun Pharmaceuticals Limited, a listed company (amalgamated). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2015) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shasun Pharmaceuticals Limited Listed CIN L24117TN1976PLC007122 | Amalgamated | 19 Apr 1976 | Chennai, Tamil Nadu | ₹1,329 Cr | 661 | 11 | View details |
Funding Insights of Shasun Pharma
Shasun Pharma has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in February 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 1
- Last Round Series A — $10M
- First Round $10M
(Feb 2012)
- Investors Count 1
All 1 funding rounds of Shasun Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2012 | $10M | Series A | – | Orbimed | – |
2 investors in total: 2 institutional.
Investors in Shasun Pharma
Shasun Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Orbimed and Strides Arcolab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields. | 1989 | orbimed.com | New York, United States | |
Manufacturer of IP-led niche finished dosage formulations and soft gelatin capsules | 1990 | stridesarco.com | Bengaluru, India |
Investor details for Shasun Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Shasun Pharmaceuticals Limited (Shasun Pharma)
Shasun Pharmaceuticals Limited is the primary company behind Shasun Pharma. The board of Shasun Pharmaceuticals Limited currently have 10 directors; the longest-serving is Abhaya Kumar Srisrimal, appointed in 1976. 15 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Abhaya Kumar Srisrimal DIN 00729827 | Managing Director | 19 Apr 1976 | 50 yrs 6 mo | Shasun Pharmaceuticals Limited |
| Vimal Kumar Srisrimal DIN 00050457 | Whole-time director | 26 Jun 1985 | 41 yrs 4 mo | Shasun Pharmaceuticals Limited |
| Shankarlal Devendra DIN 00050440 | Whole-time director | 19 Oct 2006 | 20 yrs | Shasun Pharmaceuticals Limited |
| Kannan Ramamirtham DIN 00227980 | Director | 30 Jul 2010 | 16 yrs 3 mo | Shasun Pharmaceuticals Limited |
| Rangaswamy Sundararajan DIN 00498404 | Director | 30 May 2011 | 15 yrs 5 mo | Shasun Pharmaceuticals Limited |
| Narayanaswamy Subramanian DIN 03602858 | Director | 19 Aug 2011 | 15 yrs 2 mo | Shasun Pharmaceuticals Limited |
| Sunny Sharma DIN 02267273 | Director | 29 Mar 2012 | 14 yrs 7 mo | Shasun Pharmaceuticals Limited |
| Subramanian Hariharan DIN 05297969 | CFO | 01 Apr 2014 | 12 yrs 7 mo | Shasun Pharmaceuticals Limited |
| Arun Chadra Karmakar DIN 06938042 | Director | 06 Aug 2014 | 12 yrs 3 mo | Shasun Pharmaceuticals Limited |
| Taru Mardia DIN 07191620 | Director | 30 Apr 2015 | 11 yrs 6 mo | Shasun Pharmaceuticals Limited |
People of Shasun Pharma
1 people are tracked at Shasun Pharma (1 in leadership); the tracked headcount is 661.
| Name | Role | Group |
|---|---|---|
| Founder & Owner | Leadership |
Complete people profiles for Shasun Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Shasun Pharma
Figures of Shasun Pharmaceuticals Limited, the primary company behind Shasun Pharma, for FY 2015. Revenue was ₹1,329 Cr (+8% year on year).
- ₹1,329 CrRevenue · FY 2015 · +8% YoY
- ₹13.45 CrPaid-up capital
- 661Employees (provident fund records)
Balance sheet, profit and loss, cash flow and ratios of Shasun Pharmaceuticals Limited are on its company page.
Detailed financial statements for Shasun Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shasun Pharma
Shasun Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vanquishheadacherelief.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Over-the-counter pain relief medications are manufactured for various minor aches. | vanquishheadacherelief.com | 0 | Mar 2016 | •••• |
Complete acquisition details for Shasun Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Shasun Pharma
4 dated milestones of Shasun Pharma across 40 years, from founding to its latest funding, stage changes and deals.
- Founded Shasun Pharma is founded.
- Funding First funding round of $10.0M.
- Exit Acquired by Strides Arcolab.
- Acquisition Acquires Vanquishheadacherelief.
Competitors of Shasun Pharma
Shasun Pharma has 3 listed competitors in our database, 1 of them funded. They include Indoco Remedies, Concord Biotech and BDR Pharmaceuticals Internationals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indoco.com | 1947 | Mumbai, India | 6,291 | APIs manufacturing and formulation services are provided in therapeutic segments. | ||
| concordbiotech.com | 2000 | Ahmedabad, India | 1,598 | APIs and enzymes are manufactured through fermentation by the CDMO. | ||
| bdrpharma.com | 2003 | Mumbai, India | $88.16M | 1,864 | APIs and finished products are developed and manufactured. |
Detailed competitors of Shasun Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Shasun Pharma
Websites that share an audience with Shasun Pharma (shasun.com).
Websites whose visitors overlap most with Shasun Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| orchidpharma.com | 100% | 2.8K | #4,402,094 | View details | |
| lauruslabs.com | 96% | 18.9K | #1,732,878 | View details | |
| vbshilpa.com | 69% | 6.7K | #2,056,919 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Shasun Pharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shasun Pharma
Shasun Pharma was founded in 1976 and raised its 1st funding round 36 years after it was founded.
Shasun Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Shasun Pharma is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Feb 2012.
Shasun Pharma has 661 employees.
The primary company behind Shasun Pharma, Shasun Pharmaceuticals Limited, reported revenue of ₹1,329 Cr for FY 2015, up 8% year on year.
Shasun Pharmaceuticals makes drug ingredients and finished medicines, as well as provides contract research and manufacturing services. It supplies to North America, Europe, Asia and Latin America. The company offers formulation and generic manufacturing services at its Indian sites together with contract research and manufacturing services for APIs (Active Pharmaceutical Ingredients) in India and the UK. Its service portfolio includes analytical method development and validation, scale-up technology transfer, clinical supplies manufacturing and full-scale commercial manufacturing of oral solid dosage forms. The company claims to be one of the largest global producers of generic Ibuprofen and also to have expertise in enteric coating excipients. Shasuns manufacturing facilities are certified by US FDA, MHRA, ANVISA (Brazil) and COFEPRIS (Mexico). Shasun has acquired (Rhodia Pharma Solutions business, France) and formed JV alliances (Nanoparticle Biochem, US, and Alivira Animal Health ) with foreign and domestic partners. The company went public in 1996 and merged with Strides Arcolab in Nov 2015.
Shasun Pharma's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Indoco Remedies.
Shasun Pharma has made 1 acquisition, including Vanquishheadacherelief.
Shasun Pharma has 2 investors. Key investors include Orbimed, and Strides Arcolab.
Shasun Pharma operates through Shasun Pharmaceuticals Limited.
Yes. Shasun Pharma was acquired by Strides Arcolab in September 2014.
The legal entities of Shasun Pharma currently have 11 directors, including Arun Chadra Karmakar, Taru Mardia, Abhaya Kumar Srisrimal and others.